Cargando…
Identification and evaluation of the inhibitory effect of Prunella vulgaris extract on SARS-coronavirus 2 virus entry
Until now, antiviral therapeutic agents are still urgently required for treatment or prevention of SARS-coronavirus 2 (SCoV-2) virus infection. In this study, we established a sensitive SCoV-2 Spike glycoprotein (SP), including an SP mutant D614G, pseudotyped HIV-1-based vector system and tested the...
Autores principales: | Ao, Zhujun, Chan, Mable, Ouyang, Maggie Jing, Olukitibi, Titus Abiola, Mahmoudi, Mona, Kobasa, Darwyn, Yao, Xiaojian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189562/ https://www.ncbi.nlm.nih.gov/pubmed/34106944 http://dx.doi.org/10.1371/journal.pone.0251649 |
Ejemplares similares
-
Development and characterization of influenza M2 ectodomain and/or hemagglutinin stalk-based dendritic cell-targeting vaccines
por: Olukitibi, Titus Abiola, et al.
Publicado: (2022) -
Characterization of the inhibitory effect of an extract of Prunella vulgaris on Ebola virus glycoprotein (GP)-mediated virus entry and infection
por: Zhang, Xu, et al.
Publicado: (2016) -
Significance of Conserved Regions in Coronavirus Spike Protein for Developing a Novel Vaccine against SARS-CoV-2 Infection
por: Olukitibi, Titus A., et al.
Publicado: (2023) -
SARS-CoV-2 Delta spike protein enhances the viral fusogenicity and inflammatory cytokine production
por: Ao, Zhujun, et al.
Publicado: (2022) -
Dendritic Cells/Macrophages-Targeting Feature of Ebola Glycoprotein and its Potential as Immunological Facilitator for Antiviral Vaccine Approach
por: Olukitibi, Titus Abiola, et al.
Publicado: (2019)